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Background/introduction
Focused ultrasound (FUS)-mediated opening of the
blood-brain barrier (BBB) has been used to promote drug
delivery to the brain. However, in a mouse model of
Alzheimer’s disease, FUS has proven to be effective for
reducing pathology and improving cognition, even in
the absence of exogenous drug application. We have
explored single and repeated FUS treatments in mice at
both early and late stages of plaque pathology using a
transgenic (Tg) mouse model of Alzheimer’s disease.
Methods
Mice received single or weekly FUS treatments using a
1.68 MHz transducer, (10 ms pulses, 1Hz pulse repetition
frequency, 120 second duration). Definity microbubble
contrast agent was delivered at the onset of sonication.
Effective BBB opening was confirmed using contrast
enhanced MR images. Following FUS treatments, mice
were evaluated using cognitive tests and histology.
Results and conclusions
In the Y maze with novel arm, untreated Tg mice were
found to spend significantly less time in the novel arm
compared to their non-Tg littermates.
Following FUS treatment, Tg mice performed as well as
their non-Tg counterparts. These results indicate that
repeated FUS treatments are safe and may improve cogni-
tive behavior, even in a model of late-stage AD. To support
these findings, mice treated with FUS also had reduced pla-
que burden in the brain and increased plasticity in the hip-
pocampus, both of which have been correlated to improved
learning and memory. Together this data demonstrates that
FUS-mediated BBB opening can improve cognition related
even in the absence of exogenous drug delivery and sug-
gests that FUS should be considered part of the overall
therapeutic strategy for treatment of Alzheimer’s disease.
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